When tumor-infiltrating immune cells were analyzed, significantly increased total T-cell and CD8+ T-cell infiltration into tumors was detected in response to EV alone or in combination with anti–PD-L1 treatment compared with controls (Fig. 3E). The gene discussed is CD8A; the disease is neoplasm.